KRAS G12C inhibitor 21
KRAS G12C inhibitor 21 is a KRAS G12C inhibitor extracted from patent WO2021219090A1, example 7[1].
Product Specifications
CAS Number
2737269-61-1
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-g12c-inhibitor-21.html
Solubility
10 mM in DMSO
Smiles
O=C(N1CC(C1)CN2C(C(N(C3=C2C=C(Cl)C(C4=C5C=CC=CC5=CC(O)=C4)=C3)C6=C(C(C)C)C=CC=C6)=O)=O)C=C
Molecular Formula
C34H30ClN3O4
Molecular Weight
580.07
References & Citations
[1]Quinoxaline dione derivative as irreversible inhibitor of kras g12c mutant protein. WO2021219090A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740633-500 1x 500 µL
Von Willebrand Factor (3E2D10), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040204-500 1x 500 µL
Complement C4d (C4D204), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740181-100 1x 100 µL
CD59 (heavy chain of Protectin) (BRA-10G), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 